Iskra Tomasz, Turaj Wojciech, Słowik Agnieszka, Zwolińska Grazyna, Strojny Jacek, Szczudlik Andrzej
Jagiellonian University of Cracow, Collegium Medicum.
Pol Merkur Lekarski. 2006 Nov;21(125):429-33.
of the study was to compare hemostatic markers of endothelial injury in patients with ischaemic stroke caused by large vessel disease (LVD) or small vessel disease (SVD).
We studied 30 patients with LVD and 41 patients with SVD (recruited out of 585 patients with ischaemic stroke) as well as 30 control subjects. Etiology of ischaemic stroke was established according to the TOAST criteria. In patients being 3-12 months after stroke we registered age, sex and the presence of common risk factors for stroke. We measured serum concentration of fibrinogen and plasminogen activator inhibitor 1 (PAI-1), activity of von Willebrand factor (vWF) and the level of beta-thromboglobulin (beta-TG).
The concentration of fibrinogen was greater in patients with LVD (3.56 +/-0.88 g/L) when compared to patients with SVD (2.78 +/-0.69 g/L, p<O.0005). Activity of vWF was higher in all stroke survivors (155.8+/-53.9%) when compared to controls (124.8+/-43.3%; p<0.01). It was also higher in patients with LVD (179.9+/-53.6%) than in patients with SVD (139.3+/-48. 1%; p<O.01). The level of /-TG in patients with LVD [192.0 (69.7-222.1) UI/mL] was higher than in patients with SVD [90.6 (56.6-165.8) UI/mL; p<0.05] and higher than in controls [108.7 (49.0-166.5) Ul/mL, p<0.05]. The concentration of PAl-1 was similar among all studied groups.
Stroke patients with LVD are characterized by higher concentration of fibrinogen, higher activity of vWF and higher levels of (Beta-TG) than patients with SVD. PAI-1 concentration is similar in both groups. Our results confirm the need for reanalysis of risk factors and pathomechanism of each cause of stroke separately.
本研究的目的是比较由大血管疾病(LVD)或小血管疾病(SVD)引起的缺血性中风患者内皮损伤的止血标志物。
我们研究了30例LVD患者和41例SVD患者(从585例缺血性中风患者中招募)以及30例对照受试者。根据TOAST标准确定缺血性中风的病因。在中风后3至12个月的患者中,我们记录了年龄、性别和中风常见危险因素的存在情况。我们测量了纤维蛋白原和纤溶酶原激活物抑制剂1(PAI-1)的血清浓度、血管性血友病因子(vWF)的活性以及β-血小板球蛋白(β-TG)的水平。
与SVD患者(2.78±0.69 g/L)相比,LVD患者的纤维蛋白原浓度更高(3.56±0.88 g/L,p<0.0005)。与对照组(124.8±43.3%;p<0.01)相比,所有中风幸存者的vWF活性更高(155.8±53.9%)。LVD患者(179.9±53.6%)的vWF活性也高于SVD患者(139.3±48.1%;p<0.01)。LVD患者的β-TG水平[192.0(69.7 - 222.1)UI/mL]高于SVD患者[90.6(56.6 - 165.8)UI/mL;p<0.05],且高于对照组[108.7(49.0 - 166.5)Ul/mL,p<0.05]。所有研究组中PAI-1的浓度相似。
与SVD患者相比,LVD中风患者的特点是纤维蛋白原浓度更高、vWF活性更高以及β-TG水平更高。两组中PAI-1浓度相似。我们的结果证实需要分别重新分析每种中风病因的危险因素和发病机制。